A commercialization program to match up provider, payer and pharma technology needs with willing and able healthcare startups has announced its 10 finalists. Each will receive $100,000 tied to meeting certain performance milestones. They have three to six months to work with the healthcare group they’re matched with, depending on the complexity of the program.
PILOT Health Tech NYC, developed by the New York City Economic Development Corporation and Health 2.0, is holding its demo day today at Blueprint Health’s NYC digs. The program is also supported by StartUp Health.
AdhereTech and Weill Cornell Medical Center. Product: Wireless smart pill bottle
Dr. Roy Gulick, a professor of medicine at Weill Cornell is the principal investigator of the Cornell HIV Clinical Trials Unit. Gulick will use Adhere Tech’s wireless smart pill bottles to assess patient adherence to an HIV drug regimen over a 12-week period and compare it with the usual standard of care.
BioDigital and Memorial Sloan-Kettering Cancer Center. Product: Interactive 3-D virtual body
Memorial Sloan-Kettering is using BioDigital’s interactive 3-D virtual body in the hospital’s clinical work flow as a tool to more effectively communicate complex health topics. The goal is increased patient engagement, understanding and satisfaction.
Bio-Signal Group and New York Methodist Hospital. Product: MicroEEG
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
New York Methodist Hospital will pilot Bio-Signal’s microEEG to make electroencephalogram easier to perform in a healthcare setting. The device is a U.S. Food and Drug Administration-approved, miniature, wireless system using disposable electrodes and a network of teleneurologists to provide a remote, rapid interpretation of an EEG to an emergency department physician.
eCaring and Pace University. Product: Web-based care management and monitoring system
Pace will test outcomes of the eCaring Web-based care management and monitoring system in a pilot program. It will asses the system in a population of chronically ill, multicultural older adults in Henry Street Settlement’s Vladeck Cares Naturally Occurring Retirement Community. It will evaluate the system impact on disease management, preventable events and costs.
Flatiron Health and Continuum Health Partners. Product: Big data analytics for oncology
Continuum Health Partners will use Google Ventures-backed Flatiron Health’s big data software platform for aggregated and structured clinical oncology data. The pilot will focus on measuring and improving a range of metrics relating to cancer care at their centers like operational, clinical and financial performance data.
Opticology and New York Eye & Ear Infirmary. Product: Ocular tear pen
The pilot will involve Opticology’s pen that measures glucose levels of diabetics using tears shed above the lower eyelid. It will measure the correlation between tear and blood glucose in diabetic patients.
Rip Road and VNSNY Choice SelectHealth. Product: Text messaging and engagement platform
SelectHealth and Rip Road are developing a new engagement model for Medicaid members. Rip Road’s text-messaging engagement platform will be used for member communications and patient data analysis. Adherence to appointments and medication refills are the pilot’s focus. The goals are to improve health outcomes, increase member satisfaction and retention, reduce hospitalizations and long-term care costs.
StarlingHealth and VillageCare. Product: Nurse call and bedside communication system
VillageCare is piloting StarlingHealth’s nurse call and bedside communication system. The goal is to improve patient care and satisfaction, and reduce care delivery costs at its VillageCare Center for Rehabilitation and Nursing, a 105-bed sub-acute facility. Residents will use multilingual touchscreen tablets to make specific requests. Staff will be able to view and prioritize these requests and management will have real-time visibility.
Sense Health and University Behavioral Associates. Product: Mobile patient support technology
Sense Health is working with University Behavioral Associates (affiliated with Montefiore) to pilot its mobile patient support technology with case managers and patients in the Managed Addiction Treatment Services Program. The goal is to validate a technology that efficiently helps case managers deliver high-intensity support to growing patient case loads.
Vital Care Services and Pace University. Product: Telehealth
Pace University will use a pilot to test the effectiveness of Telehealth solutions to meet current and projected needs of diverse socioeconomic communities in New York City. Pace student technicians will assist patients in taking their vitals, which are monitored remotely by a Pace registered nurse. Key objectives of the pilot are to reduce healthcare cost, increase access and quality of care, and train future working professionals at the university level.
